Showing 1216 Results
It’s “Read a Book Day”! NPC Staff Share Health-Related Books They Enjoyed
Saturday, September 6 is “Read a Book Day.” To help you celebrate, we asked the National Pharmaceutical Council staff to share with you the health- or science-related books that they've recently…
#TBT: Labor Day and Employees’ Health and Productivity
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way…
#TBT: Senior Citizens Day & Individualized Pharmaceutical Care
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way…
Get To Know NPC’s New Director Of Research, Michael Ciarametaro
Michael Ciarametaro is the latest addition to the National Pharmaceutical Council (NPC) team, joining as our new director of research. In this position, Mr. Ciarametaro plays a key role in developing…
#TBT: Then & Now: Exhibitor Appreciation Week
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way…
Individual Treatment Effects: Implications for Research, Clinical Practice, and Policy
This research outlines a framework and policy considerations to help health care stakeholders understand when it is important take patients’ individual treatment responses into account when making…
#TBT: Expanding Your Horizons: CER Continuing Education Certificate Program
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way…
#TBT: Consumer-Directed Health Plans & Employers’ Decision-Making
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way…
Real-World Impact of Comparative Effectiveness Research Findings on Clinical Practice
This study suggests that changes are needed to enable more consistent translation of research findings into clinical practice.
Will CER Really Deliver Better Patient Outcomes?
With billions of public dollars directed to comparative effectiveness research (CER) through the 2009 stimulus package and the subsequent passage of the Affordable Care Act (ACA), there is an…
#TBT: Arthur Ashe & Medication Compliance
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way…
Engaging Consumers in Today's Changing Health Care Payment and Delivery Environment
Earlier this week, National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, spoke at the Bundled Payments Summit in Washington, DC, where he and a panel of experts addressed…
NPC’s Westrich @ DIA 50th Annual Meeting: Exploring the CER Environment
The National Pharmaceutical Council’s (NPC) fourth annual health care stakeholder survey, which sheds light on the current environment for comparative effectiveness research (CER) and health care…
#TBT: V-BID: Getting More Health Out Of Every Health Care Dollar
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way…
Supporting Consumer Access to Specialty Medications Through Value-Based Insurance Design
Value-based insurance design (V-BID) is a key tactic payers and purchasers can use to promote access to high-value specialty medications.